Genomic Landscape of Somatic Alterations in Esophageal Squamous Cell Carcinoma and Gastric Cancer.

@article{Hu2016GenomicLO,
  title={Genomic Landscape of Somatic Alterations in Esophageal Squamous Cell Carcinoma and Gastric Cancer.},
  author={Nan Hu and Mitsutaka Kadota and Huaitian Liu and Christian C. Abnet and Hua Su and Hailong Wu and Neal D. Freedman and Howard H. Yang and Chaoyu Wang and Chunhua Yan and Lemin Wang and Sheryl Gere and Amy A Hutchinson and Guohong Song and Yuan Fang Wang and Ti Ding and You Lin Qiao and Jill Koshiol and Sanford M. Dawsey and Carol A Giffen and Alisa M. Goldstein and Philip R. Taylor and Maxwell P. Lee},
  journal={Cancer research},
  year={2016},
  volume={76 7},
  pages={
          1714-23
        }
}
Gastric cancer and esophageal cancer are the second and sixth leading causes of cancer-related death worldwide. Multiple genomic alterations underlying gastric cancer and esophageal squamous cell carcinoma (ESCC) have been identified, but the full spectrum of genomic structural variations and mutations have yet to be uncovered. Here, we report the results of whole-genome sequencing of 30 samples comprising tumor and blood from 15 patients, four of whom presented with ESCC, seven with gastric… 
Genomic analyses reveal SCN7A is associated with the prognosis of esophageal squamous cell carcinoma
TLDR
This study provided comprehensive analysis of the somatic mutation profiles of ESCC, and identified SCN7A and Signature_15 for the prognosis of ES CC for the first time.
Profile of esophageal squamous cell carcinoma mutations in Brazilian patients
TLDR
This is the largest mutation profile of Brazilian ESCC patients, which helps in the elucidation of the major cancer-related genes in this population, according to next-generation sequencing.
Integrative Genomic Analyses of 1,145 Patient Samples Reveal New Biomarkers in Esophageal Squamous Cell Carcinoma
TLDR
The KMT2D was associated with the multiple clinical characteristics of ESCC, and K MT2D knockdown cells showed enhanced cell migration and cell invasion, and a few neoantigens were shared between ESCC patients.
Genomic and Epigenomic Aberrations in Esophageal Squamous Cell Carcinoma and Implications for Patients.
TLDR
The genomic and epigenomic characteristics of ESCCs are reviewed, with a focus on emerging themes, and their clinical implications and future research directions are discussed.
Whole-exome sequencing in a patient with synchronous triple primary malignancies involving lung cancer: a case report
TLDR
This case is the first report of synchronous primary triple cancers covering the esophagus, lung, and liver, and highlights the complexities of MPM that even when under identical germline genetic backgrounds, the occurrence of MPMs can be a random event and driven by distinct somatic gene mutations.
Molecular landscape of esophageal cancer: implications for early detection and personalized therapy
TLDR
Recent advances in the areas of genomics and epigenomics of ESCC and EAC, their mutational signatures and immunotherapy are summarized and implications of recent advances in characterizing the genome and epigenome of EC for the discovery of diagnostic/prognostic biomarkers and development of new targets for personalized treatment and prevention are discussed.
Germline genetic variants were interactively associated with somatic alterations in gastric cancer
TLDR
Evidence is provided for the relationship between germline variants and somatic alterations, which facilitate understanding the interactive mechanism of germline variations with somatic alteration in gastric cancer development.
Identification of Radioresponsive Genes in Esophageal Cancer from Longitudinal and Single Cell Exome Sequencing.
Identification of the distinct genomic features in gastroesophageal junction adenocarcinoma and its Siewert subtypes
TLDR
Differences between GEJA and stomach/EACs at the genomic level are identified and evidence for differential treatment based on Siewert classification of GEJA is provided.
...
...

References

SHOWING 1-10 OF 26 REFERENCES
Comparative genomic analysis of esophageal adenocarcinoma and squamous cell carcinoma.
TLDR
Exomic sequencing on esophageal adenocarcinomas and ESCCs from the United States highlights key genetic differences and suggests that NOTCH1 is a tumor suppressor gene in the esophagus, and provides a genetic basis for the evolution of EACs from BarrettEsophagus.
Genomic Analyses Reveal Mutational Signatures and Frequently Altered Genes in Esophageal Squamous Cell Carcinoma
Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes
TLDR
Somatic inactivation of FAT4 and ARID1A may be key tumorigenic events in a subset of gastric cancers, and cell adhesion was the most enriched biological pathway among the frequently mutated genes.
Whole-genome reconstruction and mutational signatures in gastric cancer
TLDR
This first whole-genome analysis of two gastric adenocarcinomas revealed the architecture of a wild-type KRAS amplification, a common driver event in gastric cancer, and discovered three distinct mutational signatures - against a genome-wide backdrop of oxidative and microsatellite instability-related mutations, the first exome-specific mutational signature is identified.
Genomic and molecular characterization of esophageal squamous cell carcinoma
TLDR
The whole-exome or targeted deep sequencing of 139 paired ESCC cases and analysis of somatic copy number variations (SCNV) of over 180 ESCCs provide an important molecular foundation for understanding esophageal tumors and developing therapeutic targets.
Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer
TLDR
The mutation spectrum for ARID1A differs between molecular subtypes of gastric cancer, and mutation prevalence is negatively associated with mutations in TP53, and alterations were associated with better prognosis in a stage-independent manner.
Genetic landscape of esophageal squamous cell carcinoma
TLDR
The mutational profile of ESCC closely resembles those of squamous cell carcinomas of other tissues but differs from that of esophageal adenocarcinoma, with mutations in epigenetic modulators with prognostic and potentially therapeutic implications highlighted.
Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer
TLDR
A multidimensional and comprehensive genomic landscape that highlights the molecular complexity of gastric cancer and provides a road map to facilitate genome-guided personalized therapy is illustrated.
Exome and whole genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity
TLDR
A mutational signature defined by a high prevalence of A>C transversions at AA dinucleotides is identified and the potential activation of the RAC1 pathway is suggested as a contributor to EAC tumorigenesis.
A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma
TLDR
A genome-wide association study of gastric cancer and esophageal squamous cell carcinoma in ethnic Chinese subjects in which 551,152 SNPs were genotyped could provide insight into the high incidence of both cancers in China.
...
...